Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$267M |
| 2 |
Home Depot
HD
|
+$252M |
| 3 |
Northrop Grumman
NOC
|
+$221M |
| 4 |
Gilead Sciences
GILD
|
+$175M |
| 5 |
Dollar General
DG
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HP
HPQ
|
+$287M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$278M |
| 3 |
Biogen
BIIB
|
+$244M |
| 4 |
iShares Russell 3000 ETF
IWV
|
+$198M |
| 5 |
Exelon
EXC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 14.36% |
| 3 | Healthcare | 13.9% |
| 4 | Consumer Discretionary | 13.25% |
| 5 | Industrials | 11.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOCU
901
DocuSign
DOCU
$11.6B
| $6.15M | 0.01% |
83,261
+56,401
| +210% | +$3.88M |
|
902
Myriad Genetics
MYGN
$305M
| $6.15M | 0.01% |
225,779
-73,839
| -25% | -$2.03M |
|
|
RPAI
903
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $6.14M | 0.01% |
458,130
-6,184
| -1% | -$83.1K |
|
904
Zumiez
ZUMZ
$311M
| $6.1M | 0.01% |
176,580
+21,379
| +14% | +$676K |
|
905
Element Solutions
ESI
$8.65B
| $6.09M | 0.01% |
+524,463
| New | +$5.79M |
|
906
Centene
CNC
$32.1B
| $6.03M | 0.01% |
95,941
-679,067
| -88% | -$36.8M |
|
|
P
907
Everpure Inc
P
$34.2B
| $5.99M | 0.01% |
351,137
+91,718
| +35% | +$1.62M |
|
908
Cato Corp
CATO
$55.7M
| $5.98M | 0.01% |
343,540
-82,984
| -19% | -$1.48M |
|
|
JOYY
909
JOYY Inc
JOYY
$3.78B
| $5.95M | 0.01% |
112,684
-943
| -0.8% | -$55.5K |
|
910
TriMas Corp
TRS
$1.43B
| $5.94M | 0.01% |
189,168
-27,953
| -13% | -$862K |
|
911
Stewart Information Services
STC
$2.12B
| $5.94M | 0.01% |
145,637
+72,249
| +98% | +$2.96M |
|
912
Oppenheimer Holdings
OPY
$1.24B
| $5.9M | 0.01% |
214,798
-26,341
| -11% | -$734K |
|
913
Kemper
KMPR
$1.64B
| $5.9M | 0.01% |
76,158
+39,040
| +105% | +$2.91M |
|
914
Valmont Industries
VMI
$9.13B
| $5.86M | 0.01% |
39,145
+36,284
| +1,268% | +$5.13M |
|
915
Veracyte
VCYT
$3.54B
| $5.81M | 0.01% |
208,221
-138,400
| -40% | -$3.58M |
|
916
Integra LifeSciences
IART
$1.31B
| $5.8M | 0.01% |
99,571
+13,822
| +16% | +$823K |
|
917
Independent Bank Corp
IBCP
$815M
| $5.76M | 0.01% |
254,243
-4,199
| -2% | -$92.9K |
|
918
Acadia Pharmaceuticals
ACAD
$5.27B
| $5.75M | 0.01% |
134,397
-17,984
| -12% | -$782K |
|
|
TMX
919
DELISTED
Terminix Global Holdings, Inc.
TMX
| $5.74M | 0.01% |
149,369
-566,453
| -79% | -$24.1M |
|
920
BancFirst
BANF
$3.73B
| $5.72M | 0.01% |
91,695
-10,862
| -11% | -$639K |
|
|
SPWR
921
DELISTED
SunPower Corporation Common Stock
SPWR
| $5.69M | 0.01% |
1,114,325
+335,615
| +43% | +$1.87M |
|
922
Koppers
KOP
$872M
| $5.68M | 0.01% |
+148,607
| New | +$5.22M |
|
923
CNA Financial
CNA
$13.3B
| $5.65M | 0.01% |
126,084
+3,157
| +3% | +$143K |
|
924
Boise Cascade
BCC
$2.83B
| $5.61M | 0.01% |
153,533
-9,471
| -6% | -$344K |
|
925
Ennis
EBF
$543M
| $5.6M | 0.01% |
258,454
-6,360
| -2% | -$129K |
|
Similar funds
Cliff Asness's Q4 2019 Portfolio in Review
As of Q4 2019, Cliff Asness held 2,253 positions worth $88B, up 3.6% from $84.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness withdrew a net $3.28B in Q4 2019, closing 142 positions and reducing 1,092 holdings. Its most notable exit was iShares Russell 3000 ETF, an estimated $198M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Cliff Asness opened a new position in DaVita worth $31.1M.
- Cliff Asness's largest Q4 2019 buy was DaVita: 417,883 shares worth $31.1M.
- Cliff Asness added most to Humana in Q4 2019, an estimated $267M increase.
- Cliff Asness's biggest Q4 2019 reduction was HP, cutting an estimated $287M.
- Cliff Asness fully exited iShares Russell 3000 ETF in Q4 2019, selling an estimated $198M.
- Cliff Asness's ten largest holdings make up 13% of its $88B portfolio in Q4 2019.
- Cliff Asness opened 146 new positions and closed 142 in Q4 2019.
- Cliff Asness's portfolio value rose 3.6% quarter-over-quarter to $88B.
Based on AQR Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.